Endo, Others Look To Pare State Claims In Lidoderm MDL
Endo Pharmaceuticals Inc. and two other drugmakers have pushed a California federal court overseeing the Lidoderm multidistrict litigation to pare down state antitrust claims from updated complaints end payors and the...To view the full article, register now.
Already a subscriber? Click here to view full article